Penile Carcinoma — Trials

Penile Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

44 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04718584	the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors	completed	Phase 2	27	Dragonboat Biopharmaceutical Company LimitedINDUSTRY	1	Jul 6, 2026	clinicaltrials
NCT04224740	Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer(HERCULES)	completed	Phase 2	37	Latin American Cooperative Oncology GroupOTHER	1	Mar 13, 2024